Dakota Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.9M Buy
36,821
+6,634
+22% +$6.73M 0.73% 34
2025
Q4
$32.4M Sell
30,187
-3,008
-9% -$2.88M 0.58% 37
2025
Q3
$25.3M Sell
33,195
-3,443
-9% -$2.56M 0.51% 43
2025
Q2
$28.6M Sell
36,638
-3,336
-8% -$2.59M 0.6% 36
2025
Q1
$33M Sell
39,974
-16,175
-29% -$13.5M 0.77% 24
2024
Q4
$43.3M Sell
56,149
-1,833
-3% -$1.52M 1% 14
2024
Q3
$51.4M Sell
57,982
-833
-1% -$749K 1.16% 10
2024
Q2
$53.3M Buy
58,815
+365
+0.6% +$292K 1.25% 9
2024
Q1
$45.5M Buy
58,450
+14,808
+34% +$10.5M 1.13% 9
2023
Q4
$25.4M Sell
43,642
-5
-0% -$2.92K 0.99% 17
2023
Q3
$23.4M Sell
43,647
-5,281
-11% -$2.72M 1.03% 15
2023
Q2
$22.9M Buy
48,928
+2,566
+6% +$1.08M 1.08% 17
2023
Q1
$15.9M Buy
46,362
+3,938
+9% +$1.33M 1.06% 16
2022
Q4
$15.5M Buy
42,424
+8,215
+24% +$2.91M 1.1% 16
2022
Q3
$11.1M Sell
34,209
-4,541
-12% -$1.44M 0.9% 21
2022
Q2
$12.6M Sell
38,750
-1,462
-4% -$439K 1.16% 13
2022
Q1
$11.5M Sell
40,212
-2,169
-5% -$558K 0.93% 19
2021
Q4
$11.7M Buy
42,381
+12,461
+42% +$3.16M 1.23% 14
2021
Q3
$6.91M Buy
29,920
+21,398
+251% +$5.28M 0.8% 30
2021
Q2
$1.96M Buy
8,522
+1,190
+16% +$239K 0.23% 107
2021
Q1
$1.37M Sell
7,332
-628
-8% -$123K 0.18% 125
2020
Q4
$1.34M Buy
+7,960
New +$1.19M 0.17% 124
2020
Q1
Sell
-2,039
Closed -$268K 303
2019
Q4
$268K Buy
2,039
+29
+1% +$3.36K 0.04% 258
2019
Q3
$225K Buy
+2,010
New +$224K 0.04% 272
2019
Q2
Sell
-36,965
Closed -$4.8M 302
2019
Q1
$4.8M Buy
36,965
+29,188
+375% +$3.55M 0.95% 26
2018
Q4
$844K Buy
7,777
+1,136
+17% +$127K 0.19% 97
2018
Q3
$712K Buy
6,641
+1,891
+40% +$189K 0.16% 122
2018
Q2
$406K Buy
+4,750
New +$390K 0.11% 140

Other funds holding LLY

Dakota Wealth Management's LLY Position: Q1 2026 in Review

Dakota Wealth Management increased its Eli Lilly (LLY) stake by 22% in Q1 2026, buying an estimated $6.73M and bringing the position to 36,821 shares worth $33.9M. The position accounts for 0.73% of the portfolio, ranked #34.

Dakota Wealth Management first reported a position in LLY in Q2 2018 and has held it in 28 quarters since. The position peaked at $53.3M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dakota Wealth Management held 36,821 shares of Eli Lilly worth $33.9M as of Q1 2026.
  • Dakota Wealth Management bought 6,634 Eli Lilly shares in Q1 2026, an estimated $6.73M.
  • Eli Lilly made up 0.73% of Dakota Wealth Management's portfolio in Q1 2026, its #34 holding.
  • Dakota Wealth Management first reported a position in Eli Lilly in Q2 2018 and has held it in 28 quarters since.
  • Dakota Wealth Management's Eli Lilly position peaked at $53.3M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dakota Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.